{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:42:30Z","timestamp":1770144150954,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"DOI":"10.7759\/cureus.98835","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:42:47Z","timestamp":1765320167000},"source":"Crossref","is-referenced-by-count":1,"title":["Ozoralizumab-Induced Multifocal Demyelinating Neuropathy in a Patient With Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Yuya","family":"Ikegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Nishinaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang DI","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, et al.. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021, 22:2719. 10.3390\/ijms22052719","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"St\u00fcbgen JP","year":"2008","unstructured":"St\u00fcbgen JP. Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve. 2008, 37:281-92. 10.1002\/mus.20924","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS demyelination with TNF-\u03b1 blockers","volume":"17","author":"Kemanetzoglou E","year":"2017","unstructured":"Kemanetzoglou E, Andreadou E. CNS demyelination with TNF-\u03b1 blockers. Curr Neurol Neurosci Rep. 2017, 17:36. 10.1007\/s11910-017-0742-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2025.100567","article-title":"Effects of immunotherapy on isolated optic neuritis associated with ozoralizumab, a novel anti-tumor necrosis factor \u03b1 NANOBODY\u00ae compound: A case report","volume":"39","author":"Okitsu M","year":"2025","unstructured":"Okitsu M, Sugaya K, Shiotani Y, Takahashi K. Effects of immunotherapy on isolated optic neuritis associated with ozoralizumab, a novel anti-tumor necrosis factor \u03b1 NANOBODY\u00ae compound: A case report. eNeurologicalSci. 2025, 39:100567. 10.1016\/j.ensci.2025.100567","journal-title":"eNeurologicalSci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh PY","year":"2021","unstructured":"Van den Bergh PY, van Doorn PA, Hadden RD, et al.. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021, 28:3556-83. 10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12147","article-title":"Anti-TNF alpha medications and neuropathy","volume":"20","author":"Tsouni P","year":"2015","unstructured":"Tsouni P, Bill O, Truffert A, Liaudat C, Ochsner F, Steck AJ, Kuntzer T. Anti-TNF alpha medications and neuropathy. J Peripher Nerv Syst. 2015, 20:397-402. 10.1111\/jns.12147","journal-title":"J Peripher Nerv Syst"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2231344","article-title":"Ozoralizumab: First Nanobody\u00ae therapeutic for rheumatoid arthritis","volume":"23","author":"Tanaka Y","year":"2023","unstructured":"Tanaka Y. Ozoralizumab: First Nanobody\u00ae therapeutic for rheumatoid arthritis. Expert Opin Biol Ther. 2023, 23:579-87. 10.1080\/14712598.2023.2231344","journal-title":"Expert Opin Biol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34127","article-title":"Rheumatoid neuropathy: A brief overview","volume":"15","author":"Rajeshwari B","year":"2023","unstructured":"Rajeshwari B, Kumar S. Rheumatoid neuropathy: A brief overview. Cureus. 2023, 15:e34127. 10.7759\/cureus.34127","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-2494(97)87239-2","article-title":"The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire","volume":"148","author":"Cope A","year":"1997","unstructured":"Cope A, Ettinger R, McDevitt H. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol. 1997, 148:307-12. 10.1016\/s0923-2494(97)87239-2","journal-title":"Res Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","article-title":"Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?","volume":"44","author":"Robinson WH","year":"2001","unstructured":"Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?. Arthritis Rheum. 2001, 44:1977-83. 10.1002\/1529-0131(200109)44:9&lt;1977::AID-ART345&gt;3.0.CO;2-6","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431505-ozoralizumab-induced-multifocal-demyelinating-neuropathy-in-a-patient-with-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:42:48Z","timestamp":1765320168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431505-ozoralizumab-induced-multifocal-demyelinating-neuropathy-in-a-patient-with-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.98835","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}